Dassault Systèmes acquires ArisGlobal for $2 billion to strengthen AI in life sciences

Dassault Systèmes Secures Major Acquisition in Life Sciences

Dassault Systèmes has entered into a definitive agreement to acquire ArisGlobal from Nordic Capital for up to $2 billion, marking a significant expansion of the French software company's artificial intelligence capabilities in the life sciences sector 2

2

. The deal structure includes approximately $1.8 billion in cash at closing, with an additional $200 million in payments linked to AI-related revenue targets 2

2

. This acquisition represents a full exit for Nordic Capital, which first invested in the life sciences software company in 2019 and made an additional investment in 2021 1

1

.

ArisGlobal's Position in Pharmaceutical Technology

Founded in 1989 and headquartered in Waltham, Massachusetts, ArisGlobal develops regulatory, safety and quality software for pharmaceutical and biotech organizations 1

1

. The company's LifeSphere platform serves as a cloud-native suite that enables life sciences organizations to manage regulatory submissions, pharmacovigilance workflows and clinical data 1

1

. With more than 200 enterprise customers, including half of the world's top 50 biopharma companies, ArisGlobal processes more than 12 million safety cases annually 1

1

. The company is expected to generate approximately $175 million in revenue in 2026 1

1

.

Strategic AI Integration Through NavaX

During Nordic Capital's ownership, ArisGlobal developed NavaX, a generative AI solution for safety case processing that has been adopted by pharmaceutical companies 1

1

. This technology positions the acquisition as particularly valuable for Dassault Systèmes as it seeks to capitalize on the life sciences industry's shift to AI and precision medicine 2

2

. The company also completed two strategic acquisitions to broaden its platform capabilities under Nordic Capital's stewardship 1

1

. Aman Wasan, CEO of ArisGlobal, stated that the partnership with Nordic Capital provided the resources to build NavaX and expand the platform 1

1

.

Financial Impact and Timeline

Dassault Systèmes expects the acquisition to contribute to revenue growth and earnings per share in the first year after completion 2

2

. The transaction is subject to customary regulatory approvals and is expected to close in the second half of 2026 1

1

. Evercore and Jefferies LLC acted as financial advisors to ArisGlobal, while Kirkland & Ellis served as legal advisor 1

1

. Daniel Berglund, Partner and Head of Healthcare at Nordic Capital Advisors, expressed pride in what has been achieved together with management and looks forward to seeing the company continue to grow under Dassault Systèmes ownership 1

1

.